MeiraGTx Holdings (MGTX) Receivables - Net (2022 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Receivables - Net came in at $3.0 million in Q4 2025, up 324.33% YoY from $707000.0 in Q4 2024, and up 6.84% on a QoQ basis from $2.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Receivables - Net (2022 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 4 years of Receivables - Net data on file, last reported at $3.0 million in Q4 2025.
- Quarterly Receivables - Net rose 324.33% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 324.33% YoY) and the FY2025 annual result came in at $3.0 million, up 324.33% from the prior year.
- Receivables - Net advanced to $3.0 million in Q4 2025, from $2.8 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $32.7 million in Q2 2023 to a low of $707000.0 in Q4 2024.
- A 4-year average of $9.3 million and a median of $3.1 million in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net plunged 95.02% — and 2025, when it soared 324.33%.
- Tracing MGTX's Receivables - Net over 4 years: stood at $21.3 million in 2022, then plunged by 52.48% to $10.1 million in 2023, then plunged by 93.03% to $707000.0 in 2024, then soared by 324.33% to $3.0 million in 2025.
- The last three Receivables - Net figures came in at $3.0 million (Q4 2025), $2.8 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 734,000.00 |
| Mar 31, 2025 | 734,000.00 |
| Dec 31, 2024 | 707,000.00 |
| Dec 31, 2024 | 707,000.00 |
| Sep 30, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 10.92 Mn |
| Mar 31, 2024 | 10.92 Mn |
| Dec 31, 2023 | 10.14 Mn |
| Dec 31, 2023 | 10.14 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Sep 30, 2023 | 22.40 Mn |